Design Therapeutics, Inc. (DSGN)
15.11
-0.14
(-0.92%)
USD |
NASDAQ |
Aug 28, 16:00
15.09
-0.02
(-0.13%)
After-Hours: 20:00
Design Therapeutics Total Assets (Quarterly) : 215.13M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 215.13M |
| March 31, 2026 | 230.44M |
| December 31, 2025 | 226.75M |
| September 30, 2025 | 211.77M |
| June 30, 2025 | 222.89M |
| March 31, 2025 | 237.48M |
| December 31, 2024 | 252.09M |
| September 30, 2024 | 261.63M |
| June 30, 2024 | 269.58M |
| March 31, 2024 | 278.79M |
| December 31, 2023 | 289.64M |
| Date | Value |
|---|---|
| September 30, 2023 | 299.87M |
| June 30, 2023 | 311.63M |
| March 31, 2023 | 324.74M |
| December 31, 2022 | 341.14M |
| September 30, 2022 | 354.57M |
| June 30, 2022 | 367.93M |
| March 31, 2022 | 378.80M |
| December 31, 2021 | 390.56M |
| September 30, 2021 | 400.35M |
| June 30, 2021 | 405.15M |
| March 31, 2021 | 411.85M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amgen, Inc. | 95.64B |
| AnaptysBio, Inc. | 329.68M |
| 4D Molecular Therapeutics, Inc. | 492.62M |
| Inhibrx Biosciences, Inc. | 154.22M |
| Agenus, Inc. | 172.69M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 13.27M |
| Shareholders Equity (Quarterly) | 201.86M |
| Debt to Equity Ratio | 0.0132 |
| Current Ratio | 18.86 |
| Net Debt Paydown Yield | -0.01% |